Drug Recall


HPS Pharmacies wish to advise that Meda Pharmaceuticals, in consultation with the Therapeutic Goods Administration (TGA) have issued a drug recall for:

Dymista® Nasal Spray
Azelastine 125μg / Fluticasone 50μg
ARTG 203131

This recall has been initiated as a precautionary measure due to the discovery of some water evaporation from the container closure system during routine stability testing. As a result, the affected batches listed below may not meet product shelf-life specification at the expiry date shown on the carton. A clinical investigation confirms that the issue is unlikely to impact patient safety or efficacy.

Batch Number

Expiry Date


March 2017


March 2017


March 2017


May 2017


May 2017


June 2017


July 2017


July 2017


Please inspect your stocks and quarantine all affected products for return to your supplier for a refund.

Retain this notice in a prominent position, including in other related business units for one month. Report any problems identified with medicines, vaccines or medical devices to the TGA.

Should you require further information regarding this matter, please contact your pharmacist at HPS Pharmacies, or Meda Pharmaceuticals on 1800 048 987.

Information regarding expected dates for supply may vary subject to delays which are out of our control. HPS Pharmacies does not accept responsibility for such changes but will endeavour to keep our clients updated as information is made available from drug manufacturers or wholesalers.

Subscribe Knowledge Centre Updates

Enter your details to receive Knowledge Centre updates